Andrew H. Payne
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Andrew H. Payne.
Bioorganic & Medicinal Chemistry Letters | 2009
John B. Porter; Andrew H. Payne; Ben de Candole; Daniel Ford; Brian Hutchinson; Graham Trevitt; James M. A. Turner; Chloe Edwards; Clare Watkins; Ian Whitcombe; Jeremy Martin Davis; Colin Stubberfield
Anti-apoptotic Bcl-2 protects cells from apoptosis by binding to pro-apoptotic members of the Bcl-2 family thereby playing a role in tumour survival in response to chemo- or radiation therapy. We describe a series of phenyl pyrazoles that have high affinity for Bcl-2 and rationalise the observed SAR by means of an X-ray crystal structure.
Bioorganic & Medicinal Chemistry Letters | 2009
John B. Porter; Andrew H. Payne; Ian Whitcombe; Ben de Candole; Daniel Ford; Rachel A. Garlish; Adam Hold; Brian Hutchinson; Graham Trevitt; James M. A. Turner; Chloe Edwards; Clare Watkins; Jeremy Martin Davis; Colin Stubberfield
The separation of atropisomeric conformers of 1,2,3,4-tetrahydroisoquinoline amide Bcl-2 ligands allowed the identification of the bioactive conformer which was subsequently confirmed by X-ray crystallography.
Bioorganic & Medicinal Chemistry Letters | 2010
Ian P. Holmes; Richard Blunt; Olivier Lorthioir; Stephen M. Blowers; Andy Gribble; Andrew H. Payne; Ian G. Stansfield; Martyn D. Wood; Patrick M. Woollard; Charlie Reavill; Claire M. Howes; Fabrizio Micheli; Romano Di Fabio; Daniele Donati; Silvia Terreni; Dieter Hamprecht; Luca Arista; Angela Worby; Steve P. Watson
The identification of a highly selective D(2) partial agonist, D(3) antagonist tool molecule which demonstrates high levels of brain exposure and selectivity against an extensive range of dopamine, serotonin, adrenergic, histamine, and muscarinic receptors is described.
Bioorganic & Medicinal Chemistry Letters | 2007
Vincenzo Garzya; Ian Thomson Forbes; Andrew Derrick Gribble; Mike S. Hadley; Andrew P. Lightfoot; Andrew H. Payne; Alexander Baxter Smith; Sara E. Douglas; David Gwyn Cooper; Ian Stansfield; Malcom Meeson; Emma E. Dodds; Declan N.C. Jones; Martyn D. Wood; Charlie Reavill; Carol A. Scorer; Angela Worby; Graham J. Riley; Peter Eddershaw; Chris Ioannou; Daniele Donati; Jim J. Hagan; Emiliangelo Ratti
Tetrahedron Letters | 2005
Stuart Lang; Michael J. Corr; Neil Muir; Tanweer A. Khan; Franziska Schönebeck; John A. Murphy; Andrew H. Payne; Andrew Caerwyn Williams
Angewandte Chemie | 2008
Jonathan Clayden; Sean Parris; Nuria Cabedo; Andrew H. Payne
Organic Letters | 2003
Stuart Lang; Alan R. Kennedy; John A. Murphy; Andrew H. Payne
Archive | 2003
Steven Mark Bromidge; David Gwyn Cooper; Ian Thomson GlaxoSmithKline Forbes; Andrew Derrick GlaxoSmithKline Gribble; Christopher Norbert GlaxoSmithKline Johnson; Andrew P. Lightfoot; Stephen Frederick Moss; Andrew H. Payne; Shahzad Sharooq GlaxoSmithKline Rahman; David R. Witty
Archive | 2003
David Gwyn Cooper; Ian Thomson GlaxoSmithKline Forbes; Andrew Derrick GlaxoSmithKline Gribble; Andrew Glaxosmithkline Lightfoot; Andrew H. Payne
Archive | 2003
Ian Thomson Forbes; Andrew Derrick Gribble; Andrew P. Lightfoot; Andrew H. Payne